Jan Sebastien Boegner Page
About Jan Sebastien Boegner Page
Jan Sebastien Boegner Page is a Senior Specialist in Patient Safety at Bristol Myers Squibb in Montreal, Québec, Canada, with extensive experience in pharmacovigilance, market access, quality assurance, and clinical research.
Current Role at Bristol Myers Squibb
Jan Sebastien Boegner Page currently holds the position of Senior Specialist - Patient Safety at Bristol Myers Squibb in Montreal, Québec, Canada. His role revolves around ensuring the well-being of patients by overseeing the safety of pharmaceutical products. This position involves monitoring, evaluating, and reporting adverse drug reactions and ensuring compliance with regulatory standards.
Previous Experience in Pharmacovigilance
Jan Sebastien Boegner Page has a substantial background in pharmacovigilance, having held various roles in different organizations. Prior to his current position, he worked at Bristol Myers Squibb as a Pharmacovigilance Associate in Montreal for one month in 2021. From 2019 to 2020, he served as a Pharmacovigilance Associate II at Innomar Strategies and previously as a Pharmacovigilance Associate I for 10 months. His responsibilities in these roles included monitoring drug safety, reporting adverse events, and adhering to pharmaceutical regulations.
Professional Roles at AbbVie
At AbbVie, Jan Sebastien Boegner Page has held multiple positions that have enriched his expertise in the pharmaceutical industry. From 2017 to 2019, he worked as an Associate Safety Officer in Montreal, Quebec, focusing on drug safety and compliance. His earlier tenure at AbbVie also includes his role as an Associate Project Manager in Market Access and Government Affairs for three months in 2017, providing him with insights into regulatory and market access frameworks. Additionally, he served as a Quality Assurance Intern from 2016 to 2017.
Educational Background in Pharmaceutical Sciences
Jan Sebastien Boegner Page completed his advanced education at the Université de Montréal, specializing in Pharmaceutical Sciences. He earned a Master's Degree in Drug Development in 2017 and a DESS in Drug Development in 2016. Prior to these, he obtained a B.Sc. in Biopharmaceutical Sciences in 2015. His academic credentials, combined with his professional experience, provide him with a comprehensive understanding of the pharmaceutical landscape.
Skills and Expertise in Pharmaceutical Industry
His diverse professional experiences and educational background have equipped him with a unique skill set. He possesses a comprehensive understanding of the pharmaceutical landscape, including pharmacovigilance, market access, quality assurance, and clinical research. He is recognized for his agility, attention to detail, rigor, autonomy, communication skills, and a strong sense of responsibility. These skills enable him to optimize processes within the drug development lifecycle, leveraging his deep understanding of pharmaceutical regulations and market access strategies.